EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A new mechanism regulating microglial NLRP3 inflammasome: FMR1 mediates NLRP3 mRNA stability

Qian Deng, Qianqian Bai, Yang Yang, Wenchao Tang, Fangfei Liu, Shumin Zhang, Hao Wang, Zhehua Xing, Chi Zhang, Yanhui Yang, Qizhi Fu, Hua Fan iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0341867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Qian Deng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Microglia, Inflammasomes, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Provincial Science and Technology R&D Project, Henan Provincial Young and Middle-aged Health Science and Technology Innovation Leading Talent Training Program, Heluo Young Talents Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The NLRP3 inflammasome drives chronic inflammation and contributes to the pathogenesis of multiple sclerosis (MS). This study aimed to elucidate a novel post-transcriptional regulatory mechanism controlling NLRP3 expression in microglia under lipopolysaccharide (LPS) stimulation.

Methods

The experimental autoimmune encephalomyelitis (EAE) mouse model of MS was established and divided into four groups: Sham, EAE, EAE + Lv-con (control lentivirus), and EAE + Lv-FMR1 (FMR1-overexpressing lentivirus). BV2 microglial cells were stimulated with LPS and adenosine triphosphate (ATP). mRNA and protein levels were assessed by qPCR, western blot, immunofluorescence, and immunohistochemistry. Caspase-1 activity and IL-1β/IL-18 levels were quantified using commercial assay kits. RNA-binding proteins (RBPs) interacting with NLRP3 mRNA were identified by RNA pull-down combined with mass spectrometry. NLRP3 mRNA stability was analyzed using Actinomycin D.

Results

NLRP3 inflammasome activation was confirmed in the spinal cords of EAE mice and in LPS/ATP-stimulated BV2 cells. Lentivirus-mediated overexpression of FMR1 in EAE mice attenuated microglial activation (reduced IBA-1) and decreased NLRP3 expression compared to the EAE + Lv-con control group. Immunohistochemistry confirmed reduced caspase-1 deposition in the EAE + Lv-FMR1 group. Mechanistically, FMR1 directly interacted with the 3’ untranslated region (3’UTR) of NLRP3 mRNA in LPS/ATP-treated BV2 cells, leading to mRNA destabilization and consequent suppression of NLRP3 protein expression. Functionally, FMR1 inhibited NLRP3 inflammasome activation by downregulating NLRP3.

Conclusion

FMR1 suppresses NLRP3 inflammasome activation in both EAE mice and microglial cell models by destabilizing NLRP3 mRNA. This suggests that FMR1 possesses therapeutic potential for MS by dually regulating neuroinflammation and NLRP3-driven pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinMicrogliaInflammasomesEncephalomyelitis, Autoimmune, ExperimentalRNA StabilityFragile X Messenger Ribonucleoprotein 1AnimalsMiceLipopolysaccharidesRNA, MessengerFemaleMice, Inbred C57BLCaspase 1Cell LineMultiple SclerosisInterleukin-1beta

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNlrp3 protein, mouseFragile X Messenger Ribonucleoprotein 1LipopolysaccharidesRNA, MessengerCaspase 1Interleukin-1beta

Autor:innen und Institutionen

  • Department of Pharmacy, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, China.
  • The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Department of Trauma center, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China.
  • Department of Intensive Care Unit (Internal Medicine), The First Affiliated Hospital, And College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Luoyang Key Laboratory of Neuroimmunology and innovative Drug Screening, Luoyang, China.

ORCID-Profile: Hua Fan

Förderung

  • Henan Provincial Science and Technology R&D Project
  • Henan Provincial Young and Middle-aged Health Science and Technology Innovation Leading Talent Training Program
  • Heluo Young Talents Support Program
  • Henan Academy of Innovations in Medical Science Three Hundreds Plan

Zitieren

APA

Deng, Q., Bai, Q., Yang, Y., Tang, W., Liu, F., Zhang, S., Wang, H., Xing, Z., Zhang, C., Yang, Y., Fu, Q., & Fan, H. (2026). A new mechanism regulating microglial NLRP3 inflammasome: FMR1 mediates NLRP3 mRNA stability. PLOS One. https://doi.org/10.1371/journal.pone.0341867

Vancouver

Deng Q, Bai Q, Yang Y, Tang W, Liu F, Zhang S, et al. A new mechanism regulating microglial NLRP3 inflammasome: FMR1 mediates NLRP3 mRNA stability. PLOS One. 2026. doi:10.1371/journal.pone.0341867

BibTeX
@article{Deng2026,
  author = {Deng, Qian and Bai, Qianqian and Yang, Yang and Tang, Wenchao and Liu, Fangfei and Zhang, Shumin and Wang, Hao and Xing, Zhehua and Zhang, Chi and Yang, Yanhui and Fu, Qizhi and Fan, Hua},
  title = {A new mechanism regulating microglial NLRP3 inflammasome: FMR1 mediates NLRP3 mRNA stability},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0341867}
}
Kostenlos starten →